Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413595
Status:
COMPLETED
Last Update Posted:
2021-04-12
First Post:
2006-12-19
Brief Title:
Stroke in Young Fabry Patients sifap2 Characterization of the Stroke Rehabilitation
Sponsor:
CENTOGENE GmbH Rostock
Organization:
CENTOGENE GmbH Rostock
Study Overview
Official Title:
Stroke in Young Fabry Patients sifap2 Characterization of the Stroke Rehabilitation in Young Patients With Fabry Disease An Epidemiological International Multicenter Prognosis Study
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
sifap2
Brief Summary:
New studies indicate that in about 1 - 2 percent of the younger stroke patients the cause could have been an undiagnosed genetic disease the so called Fabry disease In this case certain fat molecules are not digested and broken down by the body - but remain in the cells These fat molecules build up to dangerous levels which start to damage the body because they accumulate eg in the walls of the blood vessels This accumulation in the blood vessels of the whole body may cause life-threatening malfunctions in the brain inducing a stroke
The purpose of this study is to investigate the stroke rehabilitation of Fabry patients during different therapeutic standard approaches for stroke and for Fabry disease if any During this study stroke patients with Fabry disease will be monitored in greater detail to determine whether the differences in treatment are significant for patient recovery and on what they depend
The purpose of this study is to investigate the stroke rehabilitation of Fabry patients during different therapeutic standard approaches for stroke and for Fabry disease if any During this study stroke patients with Fabry disease will be monitored in greater detail to determine whether the differences in treatment are significant for patient recovery and on what they depend
Detailed Description:
In a group of young stroke patients with diagnosed Fabry disease the stroke rehabilitation will be investigated during different prophylactic therapeutic approaches In this study the investigator will not be given any instructions on stroke and Fabry therapy
All patients with any etiology of stroke and a diagnosed Fabry disease submitted to the stroke unit of the participating centres which commit to work with the EUSI European Stroke Initiative recommendations for stroke management and diagnosis will be included into the study
All patients with any etiology of stroke and a diagnosed Fabry disease submitted to the stroke unit of the participating centres which commit to work with the EUSI European Stroke Initiative recommendations for stroke management and diagnosis will be included into the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None